First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Short Interest Update

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was the target of a large increase in short interest in December. As of December 15th, there was short interest totalling 400 shares, an increase of 100.0% from the November 30th total of 200 shares. Based on an average trading volume of 2,900 shares, the days-to-cover ratio is currently 0.1 days.

First Trust Nasdaq Pharmaceuticals ETF Stock Down 0.5 %

Shares of FTXH traded down $0.15 during trading hours on Friday, reaching $27.24. The company’s stock had a trading volume of 1,314 shares, compared to its average volume of 4,948. The firm has a market cap of $16.34 million, a price-to-earnings ratio of 15.98 and a beta of 0.70. The company has a 50 day moving average of $27.95 and a two-hundred day moving average of $28.25. First Trust Nasdaq Pharmaceuticals ETF has a 1-year low of $25.73 and a 1-year high of $29.72.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The company also recently disclosed a dividend, which will be paid on Tuesday, December 31st. Investors of record on Friday, December 13th will be given a dividend of $0.1304 per share. This is a boost from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13. The ex-dividend date is Friday, December 13th.

Institutional Investors Weigh In On First Trust Nasdaq Pharmaceuticals ETF

An institutional investor recently bought a new position in First Trust Nasdaq Pharmaceuticals ETF stock. International Assets Investment Management LLC purchased a new stake in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 2,662 shares of the company’s stock, valued at approximately $73,000. International Assets Investment Management LLC owned 0.41% of First Trust Nasdaq Pharmaceuticals ETF as of its most recent SEC filing.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.